000177072 001__ 177072
000177072 005__ 20240229133730.0
000177072 0247_ $$2doi$$a10.1016/S0959-8049(21)00666-3
000177072 0247_ $$2pmid$$apmid:34649646
000177072 0247_ $$2ISSN$$a0014-2964
000177072 0247_ $$2ISSN$$a0959-8049
000177072 0247_ $$2ISSN$$a1879-0852
000177072 0247_ $$2ISSN$$a(1990)
000177072 0247_ $$2ISSN$$a1879-2995
000177072 0247_ $$2ISSN$$a(1965)
000177072 037__ $$aDKFZ-2021-02278
000177072 041__ $$aEnglish
000177072 082__ $$a610
000177072 1001_ $$0P:(DE-He78)7b847bc226706f4fc5a573f1483c49d9$$aNicolay, Jan$$b0$$eFirst author$$udkfz
000177072 245__ $$aDimethyl fumarate (DMF) therapy in CTCL: results from a clinical phase II study.
000177072 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2021
000177072 3367_ $$2DRIVER$$aarticle
000177072 3367_ $$2DataCite$$aOutput Types/Journal article
000177072 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1634555760_21234
000177072 3367_ $$2BibTeX$$aARTICLE
000177072 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000177072 3367_ $$00$$2EndNote$$aJournal Article
000177072 500__ $$a#EA:A370#LA:D030#
000177072 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000177072 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000177072 650_7 $$2Other$$aCTCL
000177072 650_7 $$2Other$$aNFκB
000177072 650_7 $$2Other$$aapoptosis
000177072 650_7 $$2Other$$aclinical study
000177072 650_7 $$2Other$$atargeted therapy
000177072 7001_ $$0P:(DE-HGF)0$$aAlbrecht, Jana D$$b1
000177072 7001_ $$aAssaf, Chalid$$b2
000177072 7001_ $$aDippel, Edgar$$b3
000177072 7001_ $$aStadler, Rudolf$$b4
000177072 7001_ $$aWehkamp, Ulrike$$b5
000177072 7001_ $$aWobser, Marion$$b6
000177072 7001_ $$aGuelow, Karsten$$b7
000177072 7001_ $$aGoerdt, Sergij$$b8
000177072 7001_ $$0P:(DE-He78)92492c6eae05ee58973fc142c9201e3d$$aKrammer, Peter$$b9$$eLast author
000177072 773__ $$0PERI:(DE-600)1468190-0$$a10.1016/S0959-8049(21)00666-3$$gVol. 156 Suppl 1, p. S21 - S22$$pS21 - S22$$tEuropean journal of cancer$$v156 Suppl 1$$x0959-8049$$y2021
000177072 909CO $$ooai:inrepo02.dkfz.de:177072$$pVDB
000177072 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7b847bc226706f4fc5a573f1483c49d9$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000177072 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000177072 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)92492c6eae05ee58973fc142c9201e3d$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000177072 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000177072 9141_ $$y2021
000177072 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2021-01-28$$wger
000177072 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J CANCER : 2019$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-01-28
000177072 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEUR J CANCER : 2019$$d2021-01-28
000177072 9201_ $$0I:(DE-He78)A370-20160331$$kA370$$lKKE Dermatoonkologie$$x0
000177072 9201_ $$0I:(DE-He78)D030-20160331$$kD030$$lImmungenetik$$x1
000177072 980__ $$ajournal
000177072 980__ $$aVDB
000177072 980__ $$aI:(DE-He78)A370-20160331
000177072 980__ $$aI:(DE-He78)D030-20160331
000177072 980__ $$aUNRESTRICTED